Use in unrelated donor hematopoietic progenitor cell transplantation procedures in conjunction with appropriate preparative regimen for hematopoietic & immunologic reconstitution in patients with disorders affecting the hematopoietic system that are inherited acquired,or result from myeloablative
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/tV4T0k5
No comments:
Post a Comment